These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24142628)

  • 1. Spectroscopy imaging in intraoperative MR suite: tissue characterization and optimization of tumor resection.
    Roder C; Skardelly M; Ramina KF; Beschorner R; Honneger J; Nägele T; Tatagiba MS; Ernemann U; Bisdas S
    Int J Comput Assist Radiol Surg; 2014 Jul; 9(4):551-9. PubMed ID: 24142628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.
    Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS
    J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
    Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
    Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
    Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging.
    Zonari P; Baraldi P; Crisi G
    Neuroradiology; 2007 Oct; 49(10):795-803. PubMed ID: 17619871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis.
    Wang Q; Zhang H; Zhang J; Wu C; Zhu W; Li F; Chen X; Xu B
    Eur Radiol; 2016 Aug; 26(8):2670-84. PubMed ID: 26471274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
    Zeng QS; Li CF; Zhang K; Liu H; Kang XS; Zhen JH
    J Neurooncol; 2007 Aug; 84(1):63-9. PubMed ID: 17619225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.
    Gao W; Wang X; Li F; Shi W; Li H; Zeng Q
    Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative 3-T Magnetic Resonance Spectroscopy for Detection of Proliferative Remnants of Glioma.
    Fujita Y; Kohta M; Sasayama T; Tanaka K; Hashiguchi M; Nagashima H; Kyotani K; Nakai T; Ito T; Kohmura E
    World Neurosurg; 2020 May; 137():149-157. PubMed ID: 32035198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton magnetic resonance spectroscopy and apparent diffusion coefficient in evaluation of solid brain lesions.
    Balos DR; Gavrilović S; Lavrnić S; Vasić B; Macvanski M; Damjanović D; Opinćal TS
    Vojnosanit Pregl; 2013 Jul; 70(7):637-44. PubMed ID: 23984611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of anaplastic foci within low-grade gliomas using MR spectroscopy.
    Bradac O; Vrana J; Jiru F; Kramar F; Netuka D; Hrabal P; Horinek D; de Lacy P; Benes V
    Br J Neurosurg; 2014 Oct; 28(5):631-6. PubMed ID: 24377726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.
    Stadlbauer A; Gruber S; Nimsky C; Fahlbusch R; Hammen T; Buslei R; Tomandl B; Moser E; Ganslandt O
    Radiology; 2006 Mar; 238(3):958-69. PubMed ID: 16424238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of MR spectroscopy for assessment of glioma grading.
    Bulik M; Jancalek R; Vanicek J; Skoch A; Mechl M
    Clin Neurol Neurosurg; 2013 Feb; 115(2):146-53. PubMed ID: 23237636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative assessment using multimodal functional magnetic resonance imaging techniques in patients with brain gliomas.
    Shang HB; Zhao WG; Zhang WF
    Turk Neurosurg; 2012; 22(5):558-65. PubMed ID: 23015331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of T(1) and T(2) metabolite relaxation times in glioma and normal brain at 3T.
    Li Y; Srinivasan R; Ratiney H; Lu Y; Chang SM; Nelson SJ
    J Magn Reson Imaging; 2008 Aug; 28(2):342-50. PubMed ID: 18666155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton MR spectroscopy of tumefactive demyelinating lesions.
    Saindane AM; Cha S; Law M; Xue X; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2002 Sep; 23(8):1378-86. PubMed ID: 12223381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic challenge of lack of choline level elevation on 1H-MR spectroscopy in grade II-III gliomas.
    Bobek-Billewicz B; Heinze S; Majchrzak K; Mazgaj P; Hebda A
    Folia Neuropathol; 2024; 62(1):13-20. PubMed ID: 38741433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of malignancy in gliomas by 3T 1H MR spectroscopy .
    Jeun SS; Kim MC; Kim BS; Lee JM; Chung ST; Oh CH; Lee SY; Choe BY
    Clin Imaging; 2005; 29(1):10-5. PubMed ID: 15859012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.